Clinical trial
Predicting Response and Toxicity in Patients Receiving Lonafarnib for Breast Cancer
NCT01232881
Study timeline
Study start (unknown)2009-08-01Date precision: month
Registry last updated2011-04-28
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Interventions
Tumor SamplePROCEDURE
Serum SamplePROCEDURE
Sponsors & collaborators
Hoosier Cancer Research Networklead sponsor
United States Department of Defensecollaborator
Indiana Universitycollaborator
Emory Universitycollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01232881 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.